Torrent Pharmaceuticals

Update in progress

TORNTPHARM.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Torrent Pharmaceuticals Limited engages in R&D, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. It offers products across diabetes, antimicrobial, cardiovascular, urology, gynecology, oncology, GI, nephrology, neuro-psychiatry, dermatology, pain, anti-infectives, vitamins and minerals, and provides contract manufacturing. Brands include Tedibar, Shelcal, Unienzyme, Ahaglow. Founded 1959 as Trinity Laboratories; renamed 1971. Based in Ahmedabad, India. A subsidiary of Torrent Investments Limited.

Company score

Sentiment: 0.65; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.12; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.30; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.10; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.38; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive